Tag:
LigoCyte Pharmaceuticals
Latest Headlines
Latest Headlines
Live from BIO: Collaborations are key in vaccine industry
WASHINGTON, D.C. -- As the vaccine market continues to grow--it's forecasted to hit $40 billion globally by 2015--there is a greater need for innovation in the field. That's according to a panel of
LigoCyte rounds up $28M in third round
Bozeman, MT-based LigoCyte Pharmaceuticals has rounded up $28 million in its third round of venture capital. The money will be used for the clinical development of two lead vaccines targeting
LigoCyte forges deal with Biogen Idec
LigoCyte Pharmaceuticals has forged a deal to co-develop anti-inflammatory drugs with Biogen Idec. Researchers from both companies will be developing drugs that target CD103, a unique alphaE-beta7
